Wyeth chairman Robert Essner to retire

Share this article:
Robert Essner to retire
Robert Essner to retire

Wyeth has announced that Robert Essner will retire as chairman, effective June 27th, 2008.  Bernard Poussot, Wyeth's president and CEO will take over as chairman upon Essner's departure.

“Bob successfully led Wyeth's transformation from a holding company to what is now a world leader in pharmaceuticals that has grown in annual revenue from $14 billion in 2001 to more than $22 billion in 2007,” said Poussot in a statement.

Essner's exit from the chairman position, held since January 2003, completes the succession process which began in April 2006, when Poussot was promoted to president and vice chairman.  Poussot replaced Essner as Wyeth's CEO in January 2007.

Essner has worked at Wyeth since 1989, and was promoted to CEO in May 2001.

Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...